| Literature DB >> 30652385 |
Dongmei Wei1, Ping Wang1, Xiaoyu Niu1, Xia Zhao1.
Abstract
AIM: To compare total pelvic floor reconstruction with vaginal mesh (TVM) and laparoscopic uterus/sacrocolpopexy (LSC) for the treatment of pelvic organ prolapse (POP).Entities:
Keywords: pelvic floor disease therapy; pelvic organ prolapse; sacral colpopexy; total vaginal mesh implantation; treatment outcome
Mesh:
Year: 2019 PMID: 30652385 PMCID: PMC6590650 DOI: 10.1111/jog.13908
Source DB: PubMed Journal: J Obstet Gynaecol Res ISSN: 1341-8076 Impact factor: 1.730
Comparison of general clinical data between the two groups (cases number, %)
| General information | TVM group ( | LSC group ( |
|
|---|---|---|---|
| Age (years) | 63.9 ± 8.7 (55–75) | 52.8 ± 6.8 (40–65) | 0.037 |
| Disease course (years) | 6.9 ± 8.1 (6–10) | 7.9 ± 7.4 (5–9.5) | 0.363 |
| BMI (kg/m2) | 22.6 ± 4.9 (17.5–29.4) | 23.6 ± 3.5 (18.4–30.2) | 0.471 |
| Diabetes, | 96 (30) | 104 (29.71) | 0.937 |
| Bronchitis, | 52 (16.3) | 48 (13.7) | 0.745 |
| Difficult defecation, | 68 (21.3) | 78 (22.3) | 0.856 |
| Menopause, | 294 (92.0) | 182 (52.0) | 0.024 |
| Stress urinary incontinence, | 53 (16.6) | 54 (15.5) | 0.978 |
| Dysuria, | 86 (26.8) | 89 (25.4) | 0.894 |
| Elongation of cervix, | 72 (22.5) | 86 (24.6) | 0.147 |
| Concurrent gynecological diseases, | 56 (17.5) | 68 (19.4) | 0.065 |
| Past pelvic surgery history, | 96 (30.0) | 89 (25.4) | 0.745 |
| Detrusor overactivity, | 33 (10.3) | 10 (2.8) | 0.025 |
| Bladder outlet obstruction, | 40 (12.5) | 43 (12.3) | 0.635 |
| Hysterectomy, | 35 (10.9) | 40 (11.4) | 0.673 |
| History of uterine prolapse repair, | 32 (7.8) | 34 (9.7) | 0.765 |
| Active sexual activity, | 100 (31.3) | 140 (40.0) | 0.045 |
BMI, body mass index; LSC, laparoscopic hysterectomy of uterus/sacrocolpopexy; TVM, reconstruction with vaginal mesh.
Comparison of perioperative parameters between the two groups (n, mean ± SD)
| Perioperative parameter | TVM group ( | LSC group ( |
|
|---|---|---|---|
| Operation time (min) | 100 ± 40 | 140 ± 34 | <0.01 |
| Bleeding amount (mL) | 150 ± 80 | 74 ± 33 | <0.01 |
| Urinary catheter duration (day) | 3.5 ± 1.5 | 2.0 ± 0.5 | <0.01 |
| Hospital stay (day) | 4.5 ± 1.3 | 3.5 ± 1.3 | <0.01 |
| Hysterectomy | 72 (45.0) | 74 (47.1) | 0.11 |
| Excision of extended cervix, | 64 (40.0) | 65 (41.4) | 0.473 |
| Perineal reconstruction, | 45 (28.1) | 44 (28.0) | 0.746 |
| TVT‐O, | 18 (11.3) | 20 (12.7) | 0.574 |
LSC, laparoscopic hysterectomy of uterus/sacrocolpopexy; TVT‐O, trans‐obturator vaginal tape; TVM, reconstruction with vaginal mesh.
POP‐Q comparison between the two groups before operation and after operation during follow‐up (median of 36 months; range: 10–60).
| POP‐Q | LSC group ( |
| TVM group ( |
| Intra‐group | ||
|---|---|---|---|---|---|---|---|
| Preoperation | Postoperation | Preoperation | Postoperation | ||||
| Aa | 2.1 ± 1.1 | −2.3 ± 0.5 | <0.001 | 2.3 ± 1.2 | −2.5 ± 0.5 | <0.001 | 0.043 |
| Ba | 2.1 ± 2.5 | −2.8 ± 0.4 | <0.001 | 4.1 ± 1.5 | −2.6 ± 0.5 | <0.001 | 0.118 |
| C | 2.1 ± 3.8 | −7.1 ± 0.9 | <0.001 | 2.5 ± 3.3 | −6.1 ± 1.1 | <0.001 | 0.036 |
| Ap | 2.6 ± 1.5 | −2.8 ± 0.6 | <0.001 | 1.6 ± 1.8 | −2.7 ± 0.6 | <0.001 | 0.245 |
| Bp | 0.5 ± 2.9 | −2.5 ± 0.4 | <0.001 | 2.4 ± 2.8 | −2.7 ± 0.7 | <0.001 | 0.236 |
| PB | 2.10 ± 0.50 | 3.38 ± 0.54 | <0.001 | 2.14 ± 0.33 | 3.46 ± 0.56 | <0.001 | 0.139 |
| TVL | 7.0 ± 0.4 | 8.81 ± 0.748 | <0.001 | 7.8 ± 0.4 | 7.7 ± 0.3 | 0.163 | <0.001 |
| GH | 3.95 ± 0.54 | 2.48 ± 0.54 | <0.001 | 3.80 ± 0.43 | 2.66 ± 0.57 | <0.001 | >0.983 |
All data are given in cm (mean ± SD).
LSC, laparoscopic hysterectomy of uterus/sacrocolpopexy; POP‐Q, pelvic organ prolapsed quantification; TVM, reconstruction with vaginal mesh.
Preoperation and postoperation quality of life comparison between the two groups (score, mean ± SD)
| LSC group ( | TVM group ( | Postoperative inter‐group | |||||
|---|---|---|---|---|---|---|---|
| Preoperation | Postoperation |
| Preoperation | Postoperation |
| ||
| PFIQ‐7 | 14.6 ± 6.7 | 2.7 ± 1.4 | <0.01 | 16.7 ± 6.5 | 3.7 ± 2.2 | <0.01 | 0.735 |
| PFDI‐20 | 17.1 ± 8.1 | 2.4 ± 1.6 | <0.01 | 18.8 ± 10.7 | 4.3 ± 1.5 | <0.01 | 0.643 |
| PISQ‐12 | 50.4 ± 8.7 | 80.6 ± 6.6 | <0.01 | 40.3 ± 9.7 | 67.7 ± 8.1 | <0.01 | 0.210 |
| PGI‐C | — | 1.2 ± 0.6 | — | — | 1.8 ± 0.7 | — | 0.341 |
PISQ‐12 score comparison was based on the patients who had sexual intercourse, including 188 patients from the TVM group and 253 patients from the LSC group; P < 0.05 for the TVM group versus the LSC group. There were 35 and 37 patients lost to follow‐up in the LSC and TVM groups, respectively.
LSC, laparoscopic hysterectomy of uterus/sacrocolpopexy; PFIQ‐7, pelvic floor impact questionnaire 7; PFDI‐20, pelvic floor distress inventory‐short form 20; PGI‐C, patient global impression of change; PISQ‐12, pelvic organ prolapse/urinary incontinence sexual questionnaire‐12; TVM, reconstruction with vaginal mesh.
Comparison of intraoperative and postoperative complications and recurrence rates between the two groups (cases, %) during follow‐up (median of 36 months; range: 10–60)
| TVM group ( | LSC group ( |
| |
|---|---|---|---|
| Bladder injury | 8 (2.5) | 1 (0.03) | 0.005 |
| Intestine injury | 0 | 0 | — |
| Postoperative transient urinary retention | 14 (4.4) | 18 (6.4) | 0.178 |
| Perineal pain | 44 (14.0) | 18 (6.4) | 0.004 |
| New onset urinary incontinence | 22 (7.5) | 23 (7.2) | 0.457 |
| New stress urinary incontinence | 35 (12.0) | 38 (12.0) | 0.885 |
| New onset of pain in intercourse | 18 (6.2) | 19 (6.0) | 0.746 |
| Mesh exposure | 10 (3.4) | 6 (1.9) | 0.002 |
| Postoperative improvement of urinary incontinence | 26 (8.3) | 27 (9.5) | 0.756 |
| Postoperative recurrence | 25 (8.6) | 16 (5.0) | 0.064 |
| Infections | 0 | 0 | — |
| Fistula | 0 | 0 | — |
| Ba | 22 (88%) | 15 (93.75%) | — |
| C | 12 (48%) | 0 | — |
| Bp | 7 (28%) | 13 (81.25%) | — |
| Reoperation | 15 (60%) | 4 (25%) | — |
Among recurrences.
Procedures of reoperation were vaginal hysterectomy, anterior and posterior colporrhaphy or LSC.
Procedure of reoperation was anterior and posterior colporrhaphy.
LSC, laparoscopic hysterectomy of uterus/sacrocolpopexy; TVM, reconstruction with vaginal mesh.